Current status of MEK inhibitors in the treatment of plexiform neurofibromas
Andrea M. Gross, Eva Dombi, Brigitte C. Widemann
Topics & Concepts
NeurofibromatosisMedicineMEK inhibitorTrametinibMAPK/ERK pathwayTargeted therapyClinical trialSelumetinibOncologyInternal medicineCancerPathologyKinaseCell biologyBiologyNeurofibromatosis and Schwannoma CasesMeningioma and schwannoma managementNerve injury and regeneration